ACHC Earnings Preview: Options Price a ±15.5% Move
· The NYC Memo · ACHC reports 2026-11-04
Acadia Healthcare Company, Inc. reports November 4, 2026. The December 18, 2026 straddle implies ±15.53% against a 7.79% average reaction, with dealers long gamma and max pain at $15.
Acadia Healthcare Company, Inc. reports Q3 2026 earnings on November 4, 2026, after close. With spot at $29.62, the December 18, 2026 straddle costs $4.60 with an ATM IV of 62.5%. The options market asks for an implied move of 15.53%, framing an implied range of $25.02 to $34.22. That pricing demands more movement than history delivers. Across 7 prints counted, the average realised reaction is 7.79%, with shares finishing higher 2 times and lower 5 times.
Dealer inventory reflects a long gamma lean alongside a put/call OI of 0.42 and max pain at $15. This positioning requires market makers to trade against directional moves, dampening volatility into the print.
What the market will be watching
Trading desks focus primarily on patient admission trends and overall facility utilization across the behavioral healthcare network. Investors want clarity on labor expenses, specifically whether clinical wage inflation and reliance on contract staffing continue to erode operating margins. Any adjustments to the full-year financial outlook will dictate immediate post-earnings positioning. Beyond standard operational performance, the desk tracks execution on joint-venture partnerships, bed capacity expansion projects, and regulatory compliance updates tied to patient safety protocols.
What the options market is pricing
| Measure | Level |
|---|---|
| November 4, 2026, After Close | |
| Expiry used | December 18, 2026 (45 days out) |
| Spot | $29.62 |
| ATM straddle | $4.60 |
| Implied move | ±15.53% ($25.02 to $34.22) |
| ATM implied vol | 62.5% |
| Put/call open interest | 0.42 |
| Max pain | $15 |
| Net dealer gamma | +$0.11mn per 1% move, LONG GAMMA |
| Heaviest call strike above spot | $30 (1,540 contracts) |
| Heaviest put strike below spot | $15 (576 contracts) |
| Street EPS estimate | $0.47 |
| Street revenue estimate | $0.90bn |
Dealers sit long gamma into the print, which means their hedging leans against the move and tends to compress ACHC between catalysts. That damping disappears the moment the number crosses the tape.
How the stock has reacted before
| Report | Next-day move |
|---|---|
| Q2 2026, Jul 28 | -16.34% |
| Q1 2026, Apr 29 | -8.37% |
| Q4 2025, Jan 13 | -5.14% |
| Q3 2025, Nov 5 | -2.03% |
| Q2 2025, Aug 5 | -17.28% |
| Q1 2025, May 12 | +4.26% |
| Q4 2024, Jan 13 | +1.09% |
Across the last 7 prints the average absolute reaction is 7.79%, with 2 higher and 5 lower. The best was +4.26% and the worst -17.28%. Options are asking ±15.53%, which is 7.74 points richer than the realised average, the premium seller's case.
Where the stock is trading
| Measure | Level |
|---|---|
| Spot | $29.62 |
| 52-week range | $11.43 to $35.83 |
| Position in that range | 75% |
| From the 52-week high | -17.3% |
| From the 52-week low | +159.1% |
| Past week | -5.5% |
| Past month | +5.6% |
| Past three months | -6.5% |
| 50-day average | $29.12 |
| 200-day average | $25.88 |
How the options market is pricing it
The December 18, 2026 straddle marks $25.02 to $34.22 as the range the options market is paying for into the print, with ATM implied vol at 63% set to drain the morning after. A reaction inside that band hands the edge to premium sellers; a break outside it rewards premium buyers. Historically ACHC has moved 7.79% on earnings against the ±15.53% now implied, so the market is pricing this print richer than the recent average. Which side of that trade is right depends on the number, the guidance and where positioning unwinds.
Read the mechanics behind the crush in our earnings volatility guide, and pull the live memo for ACHC before the print.
Data as of November 3, 2026 from the live option chain, exchange price history and SEC-dated earnings reactions. This is research, not investment advice.
Related: ACHC options memo